GF
NBRV

Gabelli Funds’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Gabelli Funds’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-70
Closed -$9K – 1270
2020
Q3 		$9K Hold
70
– – ﹤0.01% 1124
2020
Q2 		$12K Hold
70
– – ﹤0.01% 1059
2020
Q1 		$10K Hold
70
– – ﹤0.01% 1074
2019
Q4 		$23K Hold
70
– – ﹤0.01% 1090
2019
Q3 		$35K Hold
70
– – ﹤0.01% 1107
2019
Q2 		$43K Hold
70
– – ﹤0.01% 1138
2019
Q1 		$43K Hold
70
– – ﹤0.01% 1125
2018
Q4 		$26K Hold
70
– – ﹤0.01% 1135
2018
Q3 		$47K Buy
+70
New +$49.6K ﹤0.01% 1142

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Gabelli Funds's NBRV Position: Q4 2020 in Review

Gabelli Funds sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 70 shares — an estimated $9K sold.

Gabelli Funds first reported a position in NBRV in Q3 2018 and held it in 9 quarters. The position peaked at $47K in Q3 2018. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

  • Gabelli Funds reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
  • Gabelli Funds sold 70 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $9K.
  • Gabelli Funds first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2018 and held it in 9 quarters.
  • Gabelli Funds's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $47K in Q3 2018.
  • 33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on Gabelli Funds's 13F filing for Q4 2020, filed 5 Feb 2021.